Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase II Study of Natto Supplementation to Prevent Loss of Bone Mass in Women Immediately After Menopause: a Randomised Double Blind Placebo-Controlled Trial

NCT00290212 is registered in ClinicalTrials.gov with University Hospital of North Norway as lead sponsor.

NCT NCT00290212
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00290212 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase II Study of Natto Supplementation to Prevent Loss of Bone Mass in Women Immediately After Menopause: a Randomised Double Blind Placebo-Controlled Trial
Lead sponsor
University Hospital of North Norway
Phase
Phase 2
Overall status
Completed
Start date
January 31, 2006
Completion date
June 30, 2007
Enrollment
304 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

perimenopausal bone loss